Inhibition of Wnt/β-Catenin Signaling in Neuroendocrine Tumors In Vitro: Antitumoral Effects

por Jin, Xi-Feng, Spöttl, Gerald, Maurer, Julian, Nölting, Svenja, Auernhammer, Christoph Josef
Publicado 2020

Antitumoral Activity of the MEK Inhibitor Trametinib (TMT212) Alone and in Combination with the CDK4/6 Inhibitor Ribociclib (LEE011) in Neuroendocrine Tumor Cells In Vitro

por Jin, Xi-Feng, Spöttl, Gerald, Maurer, Julian, Nölting, Svenja, Auernhammer, Christoph Josef
Publicado 2021

The MTH1 inhibitor TH588 demonstrates anti-tumoral effects alone and in combination with everolimus, 5-FU and gamma-irradiation in neuroendocrine tumor cells

por Aristizabal Prada, Elke Tatjana, Orth, Michael, Nölting, Svenja, Spöttl, Gerald, Maurer, Julian, Auernhammer, Christoph
Publicado 2017

Additive Anti-Tumor Effects of Lovastatin and Everolimus In Vitro through Simultaneous Inhibition of Signaling Pathways

por Nölting, Svenja, Maurer, Julian, Spöttl, Gerald, Aristizabal Prada, Elke Tatjana, Reuther, Clemens, Young, Karen, Korbonits, Márta, Göke, Burkhard, Grossman, Ashley, Auernhammer, Christoph J.
Publicado 2015